Novel ABHD12 Mutations in PHARC Patients

  title={Novel ABHD12 Mutations in PHARC Patients},
  author={Hidekane Yoshimura and Takao Hashimoto and Toshinori Murata and Kunihiro Fukushima and Akiko Sugaya and Shin-ya Nishio and Shin-ichi Usami},
  journal={Annals of Otology, Rhinology \& Laryngology},
  pages={77S - 83S}
Objective: This study examines ABHD12 mutation analysis in 2 PHARC patients, originally thought to be Usher syndrome. Methods: The ABHD12 gene of 2 patients, who suffered from deaf-blindness and dysfunctional central and peripheral nervous systems, were sequenced. Results: We identified that both cases carried the same novel splice site mutation in the ABHD12 gene. However, 1 had epilepsy and the other had peripheral neuropathy. Based on haplotype analysis, the mutation is likely not a hot spot… 

Figures and Tables from this paper

Genotype‐phenotype correlation in a novel ABHD12 mutation underlying PHARC syndrome
The genotype‐phenotype correlation of two siblings with a novel genotype underlying PHARC syndrome is described, which highlights the importance of an interdisciplinary diagnostic workup with clinical and molecular genetic testing to avoid a misdiagnosis as Charcot‐Marie‐Tooth disease or Refsum disease.
A complex homozygous mutation in ABHD12 responsible for PHARC syndrome discovered with NGS and review of the literature
A new complex homozygous mutation c.379_385delAACTACTinsGATTCCTTATATACCATTGTAGTCTTACTGCTTTTGGTGAACACA (p.Asn127Aspfs*23) is detected in a 36‐year‐old man, which suggests that the involvement of ABHD12 in polyneuropathies is possibly underestimated.
Functional validation of ABHD12 mutations in the neurodegenerative disease PHARC
The Phenotypic Spectrum of Patients with PHARC Syndrome Due to Variants in ABHD12: An Ophthalmic Perspective
From an ophthalmic perspective, clinical manifestations in patients with PHARC demonstrate variability with regard to their onset and severity, and an early multidisciplinary assessment is recommended to assess disease severity.
Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome
The clinical phenotype of disease caused by variants in CEP78, CEP250, ARSG, and ABHD12 is characterized, serving to expand the clinical phenotypes of atypical USH.
Atypical and ultra-rare Usher syndrome: a review
The molecular etiology of Usher syndrome is reviewed, highlighting rare presentations and molecular causes, and guidelines for establishing a clear nomenclature system are suggested.
The genetic and phenotypic landscapes of Usher syndrome: from disease mechanisms to a new classification
A consensus on combined criteria for Usher syndrome is crucial for the development of accurate diagnosis and to improve patient management, exploiting all the existing data to develop a combined clinical/genetic/network/functional classification forUsher syndrome.
Lipid Dyshomeostasis and Inherited Cerebellar Ataxia
This review of available references and databases on neurological disorders characterized by cerebellar ataxia shows that a subset of genes involved in lipid homeostasis form a new group that may cause ataxic disorders through a common mechanism.


Two Novel Mutations in ABHD12: Expansion of the Mutation Spectrum in PHARC and Assessment of Their Functional Effects
This is the first report of compound heterozygosity in PHARC and the first study to describe how a mutation might affect ABHD12 expression and function.
A novel Refsum-like disorder that maps to chromosome 20
Clinical and genetic characterization of a neurologic disorder resembling Refsum disease in a Norwegian consanguineous family and the findings show that the clinical syndromes that include RefSum disease are more heterogeneous than previously recognized.
Massively Parallel DNA Sequencing Facilitates Diagnosis of Patients with Usher Syndrome Type 1
This is the first report of Usher syndrome mutation analysis using massively parallel DNA sequencing and the frequency ofUsher syndrome type 1 genes in Japanese, and one case of MYO7A/PCDH15 digenic inheritance is reported.
Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome
This work reviews the 45 published mutations in CSA and CSB to date and reports 43 new mutations in these genes together with the corresponding clinical data, and considersotype–phenotype correlation hypotheses.
The clinical diagnosis and molecular genetics of kearns-sayre syndrome: a complex mitochondrial encephalomyopathy.
Advances in the understanding of the genetic background and the tissue specific effects of mtDNA deletions, in addition to resolving the inheritance pattern, will increase the ability to diagnose, manage and counsel patients with Kearns-Sayre Syndrome.
Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3
Mutations of ABHD12, an enzyme hydrolyzing an endocannabinoid lipid transmitter, cause PHARC, an entity that should be taken into account as differential diagnosis for USH3, and demonstrates the potential of comprehensive genetic analysis for improving the clinical diagnosis.
Identification of PEX7 as the second gene involved in Refsum disease.
The data show that mutations in the PEX7 gene may result in a broad clinical spectrum ranging from severe rhizomelic chondrodysplasia punctata to relatively mild RD and that clinical diagnosis of conditions involving retinitis pigmentosa, ataxia, and polyneuropathy may require a full screen of peroxisomal functions.
Genetics and pathological mechanisms of Usher syndrome
  • D. Yan, X. Liu
  • Biology, Medicine
    Journal of Human Genetics
  • 2010
A unifying hypothesis is that the USH proteins are integrated into a protein network that regulates hair bundle morphogenesis in the inner ear, which is important toward discovery of new molecular targets for diagnosis, prevention and treatment of this debilitating disorder.